Mycophenolate-Associated Bronchiectasis

Bronchiectasis in children in association with mycophenolate mofetil

Introduction Cellcept, with mycophenolate mofetil (MMF) as active substance, was granted a marketing authorisation on 14 February 1996. On 16 July 2001, paediatric transplantations were included in the therapeutic indication. The current therapeutic indication is: Cellcept is indicated in combination with cyclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patie...

Pulmonary haemosiderosis associated with bronchiectasis.

or psychic origin. In recent years, his main complaints were breathlessness on exertion and a persistent productive cough. The sputum was mucopurulent, occasionally tinged with blood, and averaged more than an ounce (30 ml.) a day. Investigation at the age of 12 revealed constant cyanosis, digital clubbing, electrocardiographic evidence of right ventricular strain, and radiological evidence of ...

Endobronchial teratoma associated with bronchiectasis and bronchiolectasis.

A teratoma in a young West Indian of Negro race is reported. The teratoma presented radiologically in the left upper lobe as an ill-defined shadow which contained a crescent-shaped translucent area and simulated a mycetoma. In addition, the left lung showed widespread nodular shadows. The left lung was resected and the teratoma was found to be endobronchial in position. This is a very rare site...

Infectious Agents Associated with Cylindrical Bronchiectasis.

rather frequent complication of bronchopneumonias occurring in Naval recruits at the Great Lakes Naval Training Center. In 1962, 137 cases of cylindrical bronchiectasis were treated at the Naval Hospital, which represents an incidence of bronchopneumonia complications of 4.5 per cent. The factors involved in the pathogenesis of bronchiectasis are complex. The host, the infectious agent, and the...

Massive atelectatic bronchiectasis associated with bronchial stenosis.